Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer: The BOLERO-6 Randomized Clinical Trial.


JERUSALEM G., de B., HURVITZ S., YARDLEY D., KOVALENKO E., EJLERTSEN B., ...More

JAMA oncology, vol.4, pp.1367-1374, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 4
  • Publication Date: 2018
  • Doi Number: 10.1001/jamaoncol.2018.2262
  • Journal Name: JAMA oncology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1367-1374
  • Istanbul University Affiliated: Yes